TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT01227941

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-4827 + pegylated liposomal doxorubicin
Description: MK-4827 will be administered according to one or two dose schedules as determined in Part A. Pegylated liposomal doxorubicin 40 mg/m\^2 will be administered intravenously on Day 3 of the cycle.
Study: NCT03720912

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online Learning Modules
Description: The modules will include information about common family management skills: social support, problem solving, communication, and supportive behavior change strategies.
Study: NCT03500146

Intervention type: DRUG
Intervention: Anticholinergic
Description: Patients prescribed medication for OAB

Intervention type: DRUG
Intervention: Anticholinergic
Description: Patients prescribed medication for OAB

Intervention type: PROCEDURE
Intervention: PTNS
Description: Patients prescribed PTNS for OAB

Intervention type: PROCEDURE
Intervention: PTNS
Description: Patients prescribed PTNS for OAB
Study: NCT02999256

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Montmorency Tart Cherry Juice

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study: NCT02823275

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Functional mobilisation
Description: functional mobilisation

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Short term plaster cast fixation
Description: 2 weeks cast immobilisation
Study: NCT02812316

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HI-BRITE Large Diameter Rigid Gas Permeable Contact Lens
Description: Approximately At least one hundred and forty (140) subjects (280 eyes) will be enrolled in this study at approximately two (2) clinical sites in Taiwan. All subjects will be fitted for and dispensed study lenses by each Investigator.
Study: NCT00909779

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Arformoterol
Description: Arformoterol Tartrate Inhalation Solution 15 mcg twice daily (BID) for a duration of one year

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo inhalation solution, twice daily (BID) for a duration of one year.
Study: NCT00963261

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: psycho-oncological intervention
Description: stepped care treatment program with different elements (patient information, exercise, psychoeducation, individual and group therapy, psycho-pharmacology)
Study: NCT04364399

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: measles, mumps and rubella combined vaccine, live
Description: One dose of measles, mumps and rubella combined vaccine, live: 0.5 ml per dose, mumps live virus not less than 4.3 lg CCID50
Study: NCT04264910

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Calm App
Description: Calm is a subscription-based meditation app which provides guided meditations, sleep stories, soundscapes and calming music. Calm offers 7 Days of Calm for those new to meditation, the daily Calm, a meditation posted daily and a library of unique 10-12 minute meditations with topics related to acceptance, anxiety, self-compassion, and physical pain (to name a few).
Study: NCT04912934

Intervention type: PROCEDURE
Intervention: A survey form was applied to individuals included in the study face-to-face.
Description: This study was completed with a descriptive, cross-sectional and relational screening model

Intervention type: PROCEDURE
Intervention: A survey form was applied to individuals included in the study face-to-face.
Description: This study was completed with a descriptive, cross-sectional and relational screening model
Study: NCT01743287

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imotun capsule
Description: Imotun capsule: Avocado-Soya Unsaponifiables 300.03mg/Cap, per oral, a capsule once a day during for 24 weeks

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Imotun capsule placebo
Description: Imotun capsule placebo: per oral, a capsule a day during 24 weeks
Study: NCT01557296

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: dietary treatment: food of small particle size
Description: Subjects with diabetes mellitus and gastroparesis. Insulin treatment. Dietary treatment with food of small particle size.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: dietary treatment: food of small particle size
Description: Subjects with diabetes mellitus and gastroparesis. Insulin treatment. Dietary treatment with food of small particle size.

Intervention type: RADIATION
Group type: PLACEBO_COMPARATOR
Intervention: Validate X-ray diagnostic method.
Description: Follow 20 radiopaque markers throw the ventricle by X-ray.

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Validate X-ray diagnostic method.
Description: Follow 20 radiopaque markers throw the ventricle by X-ray.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Can the motility be improved
Description: Registered the gastric emptying after intervention. Comparing the registrations at the beginning and at the end of the study.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Can the motility be improved
Description: Registered the gastric emptying after intervention. Comparing the registrations at the beginning and at the end of the study.

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: postprandial plasma glucose
Description: Measure the blood glucose response and gastrointestinal symptoms after a test meal

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: postprandial plasma glucose
Description: Measure the blood glucose response and gastrointestinal symptoms after a test meal
Study: NCT05128851

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: HTO
Description: Hight Tibial Osteotomy

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: HTO
Description: Hight Tibial Osteotomy

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: HTO
Description: Hight Tibial Osteotomy
Study: NCT02904148

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Shoulder mobilisation
Description: early shoulder mobilisation
Study: NCT00655824

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ofatumumab
Description: 1000 mL dilution of 35mls ofatumumab in sterile, pyrogen free, 0.9% NaCl
Study: NCT03742882

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CC-90001
Description: CC-90001
Study: NCT05120674

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: NAP
Description: During the ERRT session, the tone will be played softly so as not to interfere with the session and will be played throughout the entire session. Before sleep, the veteran will play the 40-60hz tone via their smartphone while they read their rescripted nightmare. During sleep, the 40-60hz tone will be delivered during slow-wave-sleep (SWS) by the DREEM device. The pairing of the tone with the intervention is expected to trigger benefits of the exercise in reducing nightmare disturbance during sleep.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CPT
Description: Cognitive Therapy for PTSD

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CPT
Description: Cognitive Therapy for PTSD

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CPT
Description: Cognitive Therapy for PTSD

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: ERRT
Description: ERRT asks individuals to rewrite the traumatic event that triggered their nightmares and then review the rescription before bed. This technique has been proven to drastically reduce the frequency of chronic nightmares.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ERRT
Description: ERRT asks individuals to rewrite the traumatic event that triggered their nightmares and then review the rescription before bed. This technique has been proven to drastically reduce the frequency of chronic nightmares.
Study: NCT03657186

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: One capsule, twice a day, is to be orally taken with 100 mL of water during each breakfast and lunch (approx. 5 minutes after starting eating), total 2 capsules per day.
Study: NCT00659243

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rhBSSL
Description: 0.15 g/L rhBSSL added to pasteurized breast milk; one week treatment

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: One week treatment
Study: NCT03672474

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Photobiomodulation REGEnLIFE RGn530 device
Description: For the photobiomodulation group the device is set up and activated. REGEnLIFE RGn530 medical device will follow EC labelling if proven to be safe and effective

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: SHAM REGEnLIFE RGn530 device
Description: For the photobiomodulation group the device is set up and not activated. REGEnLIFE RGn530 medical device will follow EC labelling if proven to be safe and effective
Study: NCT03854552

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 764198
Description: capsule
Study: NCT05120674

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive Behavioral Therapy for Insomnia
Description: Cognitive Behavioral Therapy for Insomnia that includes behavioral and cognitive interventions related to sleep hygiene, increasing sleep drive, and modifying behaviors that result in association between laying in bed and wakeful states.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia
Description: Cognitive Behavioral Therapy for Insomnia that includes behavioral and cognitive interventions related to sleep hygiene, increasing sleep drive, and modifying behaviors that result in association between laying in bed and wakeful states.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive Behavioral Therapy for Insomnia
Description: Cognitive Behavioral Therapy for Insomnia that includes behavioral and cognitive interventions related to sleep hygiene, increasing sleep drive, and modifying behaviors that result in association between laying in bed and wakeful states.
Study: NCT01079936

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Beginning dose level 25 mg by mouth (PO) on Days -8 to -2

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melphalan
Description: Dose level 100 mg/m2 by vein (IV) Days -3 and -2 over 30 minutes infusion

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Stem Cell Infusion
Description: Stem cell infusion on Day 0.
Study: NCT00783146

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: desloratadine
Description: desloratadine, 5 mg oral tablets, once daily for 15 days

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: fexofenadine
Description: fexofenadine, 180 mg tablets, once daily for 15 days; for purposes of blinding, fexofenadine tablets were over encapsulated

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo, once daily for 15 days
Study: NCT03854552

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: capsule
Study: NCT02211872

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 2536 BS, intravenous

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 2536 BS, intravenous
Study: NCT00508144

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alimta
Description: 500 mg/m\^2 by vein Once Over 10 Minutes Every 3 Weeks
Study: NCT03226600

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: OrACELL
Description: OrACELL is human dermis that undergoes the MATRACELL process. MATRACELL is a patented and validated process that renders allograft tissue acellular, without compromising the biomechanical or desired biochemical properties of an allograft bio-implant for its intended surgical application.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Connective Tissue Graft
Description: A measured layer of dermis is surgically removed from the palate for use as a graft to cover gingival recession
Study: NCT02142569

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sugar Pill
Description: Sugar Pills/Placebo 4 capsules/day for 12 weeks.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Sugar Pill
Description: Sugar Pills/Placebo 4 capsules/day for 12 weeks.
Study: NCT04046978

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ConM SOSIP 50 ug and ConS UFO 50 ug
Description: Intramuscular injection of synthetic viral immunogens ConM SOSIP and ConS UFO

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ConM SOSIP 50 ug and ConS UFO 50 ug
Description: Intramuscular injection of synthetic viral immunogens ConM SOSIP and ConS UFO
Study: NCT05128851

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Arthroscopy treatment
Description: Arthroscopy treatment

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Arthroscopy treatment
Description: Arthroscopy treatment

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Micro fractures
Description: Micro fractures
Study: NCT04046978

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ConM SOSIP 50 ug and ConS UFO 50 ug
Description: Intramuscular injection of synthetic viral immunogens ConM SOSIP and ConS UFO

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ConM SOSIP 50 ug and ConS UFO 50 ug
Description: Intramuscular injection of synthetic viral immunogens ConM SOSIP and ConS UFO

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mos3.1 100 ug
Description: Intramuscular injection of synthetic viral immunogen Mos3.1

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mos3.1 100 ug
Description: Intramuscular injection of synthetic viral immunogen Mos3.1

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mos3.1 100 ug
Description: Intramuscular injection of synthetic viral immunogen Mos3.1

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mos3.2 100 ug
Description: Intramuscular injection of synthetic viral immunogen Mos3.2

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mos3.2 100 ug
Description: Intramuscular injection of synthetic viral immunogen Mos3.2
Study: NCT02142569

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sugar Pill
Description: Sugar Pills/Placebo 4 capsules/day for 12 weeks.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Chinese Red Yeast Rice (CRYR)
Description: CRYR 1200mg/day, including 6 mg mevinolin as Monacolin K (2 capsules) + placebo (2 capsules) for 12 weeks.
Study: NCT04046978

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mos3.2 100 ug
Description: Intramuscular injection of synthetic viral immunogen Mos3.2

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mos3.3 100 ug
Description: Intramuscular injection of synthetic viral immunogen Mos3.3

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mos3.3 100 ug
Description: Intramuscular injection of synthetic viral immunogen Mos3.3

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mos3.3 100 ug
Description: Intramuscular injection of synthetic viral immunogen Mos3.3

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mos3.1 33 ug, Mos3.2 33 ug and Mos3.3 33 ug
Description: Intramuscular injection of synthetic viral immunogens Mos3.1, Mos3.2 and Mos3.3
Study: NCT03405519

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Radiotherapy planning using both CT and MRI scans
Description: Patients' radiotherapy will be planned using CT and MRI scans in order to establish the best methodology for planning of radiotherapy for nodal disease
Study: NCT03936647

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: surgical clipping, simple coiling, high-porosity stenting with/ without coiling, intra-arterial flow diversion with/ without coiling
Description: Treatment may include the most appropriate amongst surgical clipping, simple coiling, high-porosity stenting with or without coiling, and intra-arterial flow diversion with or without coiling, which will be predetermined by the treating physician prior to randomization.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: WEB embolization device
Description: WEB embolization device
Study: NCT02643342

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Orthokeratology

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Orthokeratology
Study: NCT04311931

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Active Dance Program
Description: All Creative Dance sessions comprised five phases: 1) opening ritual (5 min), in which participants will be welcomed and will be informed about the objectives and structure of the session; 2) warm-up (15 min), in which body muscle groups will be activated through the introduction of basics elements of movement; 3) main phase (30 min), will be proposed individual, pair and group activities, in order to achieve the objectives described above. This phase will end with a choreography composition; 4) cool-down (5 min) with stretching and physiological parameters normalization; and 5) ending ritual (5 min), in which the participants will be invented to share their sessions' experience and they will fill a sheet with attendance, exercise intensity perception (Borg Scale) and satisfaction's (Caregiver Treatment Satisfaction questionnaire).
Study: NCT00077649

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ribavirin [Copegus]
Description: 600mg po bid for 48 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ribavirin [Copegus]
Description: 600mg po bid for 48 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ribavirin [Copegus]
Description: 800mg po bid for 48 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ribavirin [Copegus]
Description: 800mg po bid for 48 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: peginterferon alfa-2a (PEG-IFN alfa-2a) [Pegasys]
Description: 180 micrograms sc weekly for 48 weeks

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: peginterferon alfa-2a (PEG-IFN alfa-2a) [Pegasys]
Description: 180 micrograms sc weekly for 48 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: peginterferon alfa-2a (PEG-IFN alfa-2a) [Pegasys]
Description: 270 micrograms sc weekly for 48 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: peginterferon alfa-2a (PEG-IFN alfa-2a) [Pegasys]
Description: 270 micrograms sc weekly for 48 weeks
Study: NCT02291588

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AMG 811
Description: A single dose of AMG 811 or placebo will be adminstered.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: contains no active drug
Study: NCT01174212

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Prophylactic Antibiotics
Description: Preoperative Antibiotics

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Control Antibiotics
Description: Antibiotics will be held until intraoperative cultures have been obtained.
Study: NCT00428870

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Arthroscopic acromioplasty or arthroscopy alone (sham) or conservative treatment (rehabilitation)

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Arthroscopic acromioplasty or arthroscopy alone (sham) or conservative treatment (rehabilitation)
Study: NCT03463720

Intervention type: OTHER
Intervention: Infected
Description: Extremity wound, infected

Intervention type: OTHER
Intervention: Not infected
Description: Extremity wounds, non-infected
Study: NCT02760420

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amoxicillin
Description: Oral amoxicillin dispersible tablets (DT), 250 mg tablets, given according to age band, two times daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Oral placebo dispersible tablets (DT), 250 mg tablets, given according to age band, two times daily
Study: NCT00394173

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DNK333
Description: DNK333 25mg b.i.d. given orally for 4 weeks

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo
Study: NCT03077646

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Be SMART
Description: An educational campaign that is non-political reviewing gun safety measures for preventing firearm injuries in children. There is both a video and written materials reviewing the information. The acronym SMART stands for: Secure all guns in your home, Model responsible behavior, Ask about unsecured guns in other homes, Recognize the risks of teen suicide, Tell your peers to be SMART

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control: TSE
Description: A video called Kids and Smoke Don't Mix and handouts on tobacco smoke exposure (TSE) developed by the New York state quit-line.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Be SMART + MD review
Description: An educational campaign that is non-political reviewing gun safety measures for preventing firearm injuries in children. There is both a video and written materials reviewing the information. The acronym SMART stands for: Secure all guns in your home, Model responsible behavior, Ask about unsecured guns in other homes, Recognize the risks of teen suicide, Tell your peers to be SMART.~After being presented to parents/guardians via video and handouts, this information will be reviewed in person with a Physician.
Study: NCT00553319

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo group

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adderall-XR
Description: Adderall-XR 60mg/day

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adderall-XR
Description: Adderall-XR 80mg/day
Study: NCT04651153

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: UCB7853
Description: Subjects will receive UCB7853 at pre-specified time-points.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subjects will receive Placebo at pre-specified time-points.
Study: NCT02727452

Intervention type: OTHER
Group type: OTHER
Intervention: Skin-to-skin contact

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Skin-to-skin contact
Study: NCT00428870

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Arthroscopic acromioplasty or arthroscopy alone (sham) or conservative treatment (rehabilitation)
Study: NCT00938691

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intradermal Suture

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Intradermal Suture